Assertio Holdings | DEPO - Gross Profit On Sales

Stock Price
19.39
Daily Change
-0.14 -0.72%
Monthly
64.74%
Yearly
86.88%
Q1 Forecast
18.01

Assertio Holdings reported $22.24M in Gross Profit on Sales for its fiscal quarter ending in June of 2024.





Gross Profit On Sales Change Date
ANI Pharmaceuticals USD 124.18M 12.39M Dec/2025
Assertio Holdings USD 22.24M 970K Jun/2024
Aurora Cannabis CAD 46.62M 14.33M Dec/2025
Cara Therapeutics USD 2.57M 1.11M Mar/2025
Daiichi Sankyo JPY 439.83B 95.05B Dec/2025
Ironwood Pharmaceuticals USD 85.24M 44.1M Jun/2025
J&J USD 16.6B 118M Dec/2025
Knight Therapeutics CAD 64.72M 8.91M Dec/2025
Merck USD 13.42B 431M Sep/2025
Nektar Therapeutics USD 13.75M 650K Jun/2024
Omeros USD -33.16M 18.52M Jun/2024
Pfizer USD 3.54B 7.61B Sep/2025
Teva Pharmaceutical Industries USD 2.66B 351M Dec/2025